What Should You Actually Test? A Plain Guide to Choosing a Panel

The consumer testing market competes on biomarker count. One company advertises 29, another 60, another 160. Very little of that marketing addresses the only question that matters: which of these numbers would change what you do?

Start with what changes decisions

A result is worth measuring if there is a plausible action attached to it. For most adults with no symptoms, that shortlist is not long:

• HbA1c — the single most informative metabolic number, and abnormal results have clear, well-established actions.
• A lipid panel — cholesterol, HDL, triglycerides, with LDL calculated from them.
• Kidney and liver — creatinine with eGFR, and ALT. Quiet, common, and treatable when caught early.
• Thyroid (TSH) — a common and very treatable cause of fatigue and weight change.
• Ferritin — iron deficiency is common, particularly in menstruating women, and often missed.
• Vitamin D — widely low and simple to correct.

That is a modest list. It is also most of the value.

Add markers for a reason, not for a number

Hormone panels make sense if you have symptoms, are on therapy, or are investigating fertility. Prostate monitoring makes sense with age or on testosterone. Inflammatory markers make sense in a specific clinical context. Ordered without a question in mind, each one mostly generates a result you then have to explain away.

The problem with very large panels

Reference ranges are usually built so that 95% of a healthy population falls inside them. That means roughly one in twenty results is flagged in a perfectly healthy person, by design. Order 160 markers and you should expect around eight abnormal flags with nothing wrong with you.

Some of those will worry you. Some will lead to follow-up testing that carries its own cost and risk. This is a well-described phenomenon, not a criticism of any particular company — but it is worth understanding before you buy the biggest panel on offer.

Repeat beats breadth

One result is a snapshot with no context. The same marker measured twice, six or twelve months apart, tells you a direction — and direction is what actually informs a decision. If you are choosing between a huge one-off panel and a focused one you will repeat, take the focused one.

And ask who is running it

Many consumer testing companies are marketing businesses that send your sample to a third-party laboratory. That is not inherently wrong, but it does mean nobody in the chain can answer a detailed question about how your result was produced. Ask who holds the CLIA certificate, what instrument the assay ran on, and whether a result is measured or calculated. A laboratory can answer all three.